The seven types of drug discovery waste: toward a new lean for the drug industry.
作者信息
Uitdehaag Joost C M
出版信息
Drug Discov Today. 2011 May;16(9-10):369-71. doi: 10.1016/j.drudis.2011.02.013. Epub 2011 Feb 25.
PMID:21354473
Abstract
摘要
相似文献
1
The seven types of drug discovery waste: toward a new lean for the drug industry.
Drug Discov Today. 2011 May;16(9-10):369-71. doi: 10.1016/j.drudis.2011.02.013. Epub 2011 Feb 25.
2
The clinical utility index as a practical multiattribute approach to drug development decisions.临床效用指数作为一种用于药物研发决策的实用多属性方法。
Clin Pharmacol Ther. 2009 Jul;86(1):105-8. doi: 10.1038/clpt.2009.71. Epub 2009 May 20.
3
Regulatory science and the role of the regulator in biomedical innovation.监管科学以及监管机构在生物医学创新中的作用。
Clin Pharmacol Ther. 2012 Mar;91(3):347-52. doi: 10.1038/clpt.2011.352.
4
Does process excellence handcuff drug development?卓越的流程是否束缚了药物研发？
Drug Discov Today. 2011 May;16(9-10):377-81. doi: 10.1016/j.drudis.2011.02.010. Epub 2011 Feb 22.
5
Interview with Dr Bowsher.对鲍舍尔博士的采访。
Bioanalysis. 2013 Jun;5(11):1337-40. doi: 10.4155/bio.13.77.
6
Bilski blundering biotech.比尔兹利，蹩脚的生物技术公司。
Nat Biotechnol. 2009 Mar;27(3):245-8. doi: 10.1038/nbt0309-245.
7
What matters most in commercial success: first-in-class or best-in-class?商业成功中最重要的是什么：同类首创还是同类最佳？
Nat Rev Drug Discov. 2013 Jun;12(6):419-20. doi: 10.1038/nrd4035.
8
Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines.征求澳大利亚制药行业员工对合作和合理用药概念的看法。
Intern Med J. 2011 Apr;41(4):314-20. doi: 10.1111/j.1445-5994.2010.02239.x.
9
Mads Krogsgaard Thomsen. Interview by Asher Mullard.马兹·克罗斯加德·汤姆森。阿舍·穆拉德采访。
Nat Rev Drug Discov. 2014 Feb;13(2):96-7. doi: 10.1038/nrd4238.
10
The importance of triaging in determining the quality of output from high-throughput screening.在确定高通量筛选产出质量方面，分类的重要性。
Future Med Chem. 2015;7(14):1847-52. doi: 10.4155/fmc.15.121. Epub 2015 Sep 30.
Zotero 插件